Delta Global Management LP Decreases Holdings in The Cooper Companies, Inc. $COO

Delta Global Management LP trimmed its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 48.3% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 16,386 shares of the medical device company’s stock after selling 15,328 shares during the quarter. Delta Global Management LP’s holdings in Cooper Companies were worth $1,123,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently modified their holdings of the company. CYBER HORNET ETFs LLC purchased a new stake in Cooper Companies during the second quarter valued at $36,000. MUFG Securities EMEA plc purchased a new position in Cooper Companies in the second quarter worth about $42,000. Quent Capital LLC bought a new stake in shares of Cooper Companies during the 3rd quarter valued at about $44,000. Mather Group LLC. bought a new stake in shares of Cooper Companies during the 3rd quarter valued at about $56,000. Finally, Federated Hermes Inc. purchased a new stake in shares of Cooper Companies during the 3rd quarter valued at about $58,000. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Cooper Companies Trading Up 1.6%

Shares of NASDAQ:COO opened at $71.04 on Tuesday. The stock has a 50 day moving average of $80.99 and a 200 day moving average of $76.01. The company has a market cap of $13.86 billion, a PE ratio of 35.17, a price-to-earnings-growth ratio of 1.80 and a beta of 1.02. The Cooper Companies, Inc. has a 12-month low of $61.78 and a 12-month high of $89.83. The company has a current ratio of 1.34, a quick ratio of 0.79 and a debt-to-equity ratio of 0.22.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, March 5th. The medical device company reported $1.10 EPS for the quarter, topping analysts’ consensus estimates of $1.03 by $0.07. The company had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $1.02 billion. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. The firm’s revenue was up 6.2% compared to the same quarter last year. During the same quarter last year, the business earned $0.92 EPS. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. As a group, equities research analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Insider Activity

In other news, Director Cynthia L. Lucchese bought 1,784 shares of the stock in a transaction that occurred on Monday, December 22nd. The shares were bought at an average price of $84.06 per share, for a total transaction of $149,963.04. Following the purchase, the director owned 9,445 shares in the company, valued at $793,946.70. This represents a 23.29% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, Director Lawrence Erik Kurzius bought 2,000 shares of the company’s stock in a transaction that occurred on Wednesday, December 17th. The stock was purchased at an average cost of $82.50 per share, with a total value of $165,000.00. Following the acquisition, the director directly owned 7,777 shares in the company, valued at $641,602.50. This trade represents a 34.62% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have bought 4,784 shares of company stock worth $397,093 in the last three months. Company insiders own 2.08% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently issued reports on COO shares. Citigroup dropped their price objective on shares of Cooper Companies from $88.00 to $87.00 and set a “neutral” rating on the stock in a report on Friday, March 6th. William Blair raised shares of Cooper Companies to a “strong-buy” rating in a report on Friday, January 30th. Robert W. Baird lifted their price target on shares of Cooper Companies from $85.00 to $98.00 and gave the stock an “outperform” rating in a research note on Friday, December 5th. Rothschild & Co Redburn downgraded shares of Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 price objective for the company. in a research report on Wednesday, March 4th. Finally, JPMorgan Chase & Co. upped their price objective on Cooper Companies from $66.00 to $78.00 and gave the stock a “neutral” rating in a research note on Friday, December 5th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Cooper Companies currently has an average rating of “Moderate Buy” and an average target price of $90.79.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.